BIOMAT Database Logo BIOMAT Database Logo

Effect of corticosteroid therapy on bromsulphthalein excretion in active chronic hepatitis. 1968

G C Cook, and M Velasco, and S Sherlock

UI MeSH Term Description Entries
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006505 Hepatitis INFLAMMATION of the LIVER. Hepatitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

G C Cook, and M Velasco, and S Sherlock
Corticosteroid therapy for chronic active hepatitis.
October 1976, Annals of internal medicine,
G C Cook, and M Velasco, and S Sherlock
Corticosteroid therapy for chronic active hepatitis.
July 1984, The American journal of gastroenterology,
G C Cook, and M Velasco, and S Sherlock
Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy.
November 1985, Gastroenterology,
G C Cook, and M Velasco, and S Sherlock
Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.
April 1971, The Quarterly journal of medicine,
G C Cook, and M Velasco, and S Sherlock
Short-term corticosteroid therapy for chronic active hepatitis B.
January 1990, Digestion,
G C Cook, and M Velasco, and S Sherlock
Corticosteroid-treated chronic active hepatitis in remission: uncertain prognosis of chronic persistent hepatitis.
January 1981, The New England journal of medicine,
G C Cook, and M Velasco, and S Sherlock
Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis.
January 1987, Gastroenterology,
G C Cook, and M Velasco, and S Sherlock
Corticosteroid therapy for chronic active hepatitis B: is a little to much?
January 1986, Hepatology (Baltimore, Md.),
G C Cook, and M Velasco, and S Sherlock
Follow-up ten years after corticosteroid therapy for chronic active hepatitis type B.
April 1980, Hepato-gastroenterology,
G C Cook, and M Velasco, and S Sherlock
Effect of exogenous corticosteroid therapy on growth in children with HBsAg-negative chronic aggressive hepatitis.
January 1984, Journal of pediatric gastroenterology and nutrition,
Copied contents to your clipboard!